Females tend to exhibit worse cognitive outcomes than males after pediatric cranial radiation therapy (CRT). Previous literature suggest that these sex differences may be driven by neuroinflammatory responses that involve CCL2. The objective of this study was to determine whether protection from Ccl2 knockout is mediated by sex hormones or sex chromosomes. We employ MRI on a CRT mouse model with mixed sex hormone and chromosome complements (i.e., four core genotypes model) to determine neuroanatomical changes. We found that both male chromosome and male sex hormones separately benefit regions of the brain in CCL2 deficient mice after CRT.
No takes yet. Share an insight, caveat, or question.
Yeung et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: